(525)
Total revenues 445,886 392,186
Benefits and expenses:
Claims incurred 365,585 310,033
Operating expenses 63,572 57,944
Total operating costs 429,157 367,977
Interest expense 3,749 3,938
Total benefits and expenses 432,906 371,915
Income before taxes 12,980 20,271
Income tax expense 3,509 4,781
Net income $9,471 $15,490
Basic net income per share $0.29 $0.58
Diluted earnings per share $0.29 $0.58
Condensed Consolidated Statements of Cash Flows
(Dollar amounts in thousands, except per share data)
For the Nine Months Ended
September 30,
Unaudited Historical
2008 2007
Net cash (used in) provided by
operating activities $(19,894) $51,490
Cash flows from investing activities:
Proceeds from investments sold or matured:
Securities available for sale:
Fixed maturities sold 162,802 101,828
Fixed maturities matured 65,088 25,733
Equity securities 4,449 1,000
Securities held to maturity:
Fixed maturities matured 20,107 7,172
A
'/>"/>
SOURCE Triple-S Management Corporation Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Related medicine news :1.
Triple-S Management Corporation Schedules Second-Quarter Earnings Release and Webcast2.
Triple-S Management Corporation Reports First Quarter 2008 Results; Cites Growth Resulting From Strong Market Position3.
Triple-S Management Corporation Schedules First-Quarter Earnings Release and Webcast4.
Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 20075.
Triple-S Management Corporation to Present at UBS Global Healthcare Conference6.
Triple-S Management Corporation Announces Full Exercise of Underwriters Over-Allotment Option7.
PharmaSmart International, Inc. Redefines Blood Pressure Management through Technology and Pharmacy Focused Patient Services8.
CareAnalyzer From DST Health Solutions Helps Health Plans Improve Care Management and Quality for Members9.
Wound Management Technologies, Inc. Announces Strategic Business Directions, Recent Conference Presentation, in Addition to Symposium Exhibit Plans for Las Vegas10.
Four Companies Are First to Achieve Accreditation Under Two New URAC Pharmacy Quality Management(SM) Programs11.
Alexion Pharmaceuticals Chooses Blue Mountain Regulatory Asset Manager(R) for Best-in-class Calibration Management Integrated with SAP(R)